ClinicalTrials.gg
CompletedNCT05240014Updated Nov 18, 2026Results posted

Enhancing Voluntary Motion in Broad Patient Populations With Modular Powered Orthoses

An interventional study of Modular powered orthosis in Lower-limb Orthoses, Frailty/Sarcopenia and Chronic Overuse Musculoskeletal Injuries, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by University of Michigan · Not applicable, Interventional, and Other

How we know

Updated Nov 18, 2026Now CompletedResults posted+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Not applicable
Ages
18 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 185 studies in Frailty with a site in United States — 48 open to participants now, 61 under way, 1 of them phase 3. Frailty · United States.

Enrollment
101st of 142
27 · median 42
Started
2022
with 18 others
No phase
93 of 185
27 open now
Registered
112th of 185
by date

Among the 185 studies in Frailty with a site in United States, this one is the 101st largest by enrollment of the 142 interventional ones that give a count, is one of 19 that started in 2022, is one of 93 with no phase, and was the 112th registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

48 of the 185 studies in Frailty with a site in United States are open now. Recruiting first, the newest first:

43 more — sign in →

All 48 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 18 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 185 studies in Frailty with a site in United States, or all of them as a file.
02

Study summary

The overall goal of this project is to develop modular, lower-limb, powered orthoses that fit to user-specific weakened joints and control force/torque in a manner that enhances voluntary motion in broad patient populations. This project aims to establish feasibility of assisting different populations with these modular powered orthoses. The investigators hypothesize that assisting lower-limb musculature with modular powered orthoses will improve 1) lifting/lowering posture in able-bodied subjects and 2) functional outcomes in elderly subjects.

Read the detailed description

The overall goal of this project is to develop modular, lower-limb, powered orthoses that fit to user-specific weakened joints and control force/torque in a manner that enhances voluntary motion in broad patient populations. Conventional orthoses tend to immobilize joints, and emerging powered orthoses constrain voluntary motion by using highly geared electric motors and/or control methods that force the user to follow a specific gait pattern. Consequently, these devices have not seen widespread success across populations with weakened voluntary control due to advanced age, musculoskeletal disorders, etc. These heterogeneous populations require partial, not full, assistance of user-specific muscle groups during daily activities. However, there is a fundamental gap in knowledge about how to design and control powered orthoses to assist the user without constraining their motion. The central hypothesis of this project is that high-torque, low-inertia motor systems controlled with energetic objectives will enable modular powered orthoses to partially assist the joints. High-torque electric motors combined with minimal transmissions can be freely rotated (i.e., backdriven) by human joints, allowing the use of an emerging torque control method called energy shaping to reduce the perceived weight/inertia of the body during any motion. By mounting these modular actuators to commercial orthoses, this technology will be easily prescribed/configured by clinicians. This project aims to establish feasibility of assisting different populations with modular powered orthoses. The investigators hypothesize that assisting lower-limb musculature with modular powered orthoses will improve 1) lifting/lowering posture in able-bodied subjects and 2) functional outcomes in elderly subjects.

03

Conditions studied

  • Lower-limb Orthoses
  • Frailty/Sarcopenia
  • Chronic Overuse Musculoskeletal Injuries
04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion criteria for able-bodied, young participants will be:

  • Aged between 18 to 65 years
  • Weigh less than 250 lbs due to limitations in the design of the orthoses
  • Ability to lift and lower a 10 kg weight using the neutral-spine squat technique for 10 repetitions

Exclusion criteria for able-bodied, young adult participants will be:

  • Pregnant (self-report)
  • Any significant neuromuscular or musculoskeletal disorder that would interfere with the study
  • Prior history of chronic lower-back pain
  • Unable to walk for 20 minutes
  • History of any cardiovascular, vestibular, or visual diseases and/or impairments that may interfere with the study
  • Cognitive deficits that would impair their ability to give or impair their ability to follow simple instructions during the experiments. Cognitive deficits will be determined by a (MMSE) score of \<22.
  • Adults with a known allergy to medical grade tape

Inclusion criteria for elderly participants will be:

  • Aged between 65 to 85 years
  • Weigh less than 250 lbs due to limitations in the design of the orthoses
  • Ability to walk 6 minutes without assistance from a person (may use walking aid)

Exclusion criteria for elderly participants will be:

  • Pregnant (self-report)
  • Significant pain due to arthritis or other joint problems that would limit their ability to walk
  • Any recent lower-extremity fracture (within 3 months)
  • Significant neurological (e.g., stroke), orthopedic, or cardiovascular disorder that may affect the ability to walk
  • Advised by a physician not to walk or exercise
  • Uncontrolled hypertension or diabetes
  • Cognitive deficits or visual impairment that would impair their ability to give informed consent or impair their ability to follow simple instructions during the experiments. Cognitive deficits will be determined by a Mini-Mental State Examination (MMSE) score of \<22.
  • Adults with a known allergy to medical grade tape
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    Exoskeleton

    Participants in this arm of the study will perform various tasks while wearing the modular powered orthosis

    Device: Modular powered orthosis

Interventions

  • DeviceModular powered orthosis

    This study will investigate modular, lower-limb, powered orthoses that fit to user-specific weakened joints and control force/torque in a manner that enhances voluntary motion in broad patient populations. The central hypothesis is that high-torque, low-inertia motor systems controlled with energetic objectives will enable modular powered orthoses to partially assist the joints. High-torque electric motors combined with minimal transmissions can be freely rotated (i.e., backdriven) by human joints, allowing the use of an emerging torque control method called energy shaping to reduce the perceived weight/inertia of the body during any motion. By mounting these modular actuators to commercial orthoses, this technology will be easily prescribed/configured by clinicians.

06

What researchers measure

Primary outcomes

  1. Muscle Effort (% MVC) With and Without Powered Orthosis - Able Bodied 1

    For each orthosis module tested, electromyography (EMG) readings will be normalized per-muscle by the peak EMG observed during the no-orthosis condition, and then averaged over the cycle and across repetitions to obtain "normalized exertion" values. Data are presented as Muscle Effort (% Maximum Voluntary Contraction (MVC). Participants completed active movement trials and multi-terrain circuit loops under randomized conditions: 1) Baseline unassisted (No Exoskeleton) and 2) Assisted with active orthosis joint configurations running trajectory-free, task-invariant torque control via energy-shaping algorithms.

    Time frame: 1 day

  2. Quadriceps Muscle Effort (% MVC) With and Without Powered Orthosis - Able Bodied 2

    We estimated quadriceps effort during six different lifting, lowering, and carrying (LLC) tasks (lifting-lowering (LL), level walking (LW), ramp ascent (RA), ramp descent (RD), stair ascent (SA), and stair descent (SD)) for the no-exo and exo conditions in a nonfatigued state. Muscle effort was calculated as the mean root mean square EMG, normalized to % maximum voluntary contraction (%MVC), over the gait/task cycle. Quadriceps effort was estimated by taking the weighted mean of the efforts of the vastus medialis oblique (VMO), vastus lateralis (VL), and rectus femoris (RF) based on their respective physiological cross-sectional areas.

    Time frame: 1 day

  3. Time to Complete 10 Reps of Lifting/Lowering

    Time to complete 10 reps of L\&L will be measured post-fatigue in healthy subjects. The reported outcome is measured in seconds to completion.

    Time frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)

  4. Gait Speed

    Gait speed will be determined by the time to complete a 10-meter walk test. This will be the primary outcome measure for elderly subjects.

    Time frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)

  5. Powered Orthosis Effect (Biological Torque)

    For each orthosis module tested, peak biological torque (estimated by inverse dynamics) will be averaged across repetitions. Performance will be assessed by the difference between the orthosis condition and no-orthosis condition, averaging across tasks. Participants walked on a Bertec instrumented treadmill with a level slope at 1.0 and 1.2 m/s, a 5◦-inclined and 5◦-declined slope at 1.0 m/s, and a 10◦-inclined and 10◦-declined slope at 0.8 m/s. Participants also performed stair ascent and descent on a 5-step staircase with 7 in (178 mm) step height, and STS transitions from a knee-height chair. All activities were performed both with the powered exoskeleton and without. Results are presented as mean torque (Newton-meters per kilogram (Nm/kg).

    Time frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)

  6. Minimum Chair Height for Successful Sit-to-stand

    We will evaluate the minimum chair height from which elderly participants can successfully rise with and without the knee exoskeleton.

    Time frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)

  7. Joint Power

    For elderly participants, we will evaluate the peak values of biological and total (exo+biological) joint power at the hip with and without the exoskeleton. Results presented as mean power in watts per kilogram (W/kg).

    Time frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)

Secondary outcomes

  1. User Satisfaction

    User satisfaction / perception of device effectiveness over an ambulation circuit (sit-to-stand, walk up and down a ramp, walk up and down a staircase) will be measured post-fatigue in healthy subjects using a modified Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) survey. The purpose of the scale is to evaluate user device satisfaction and consists of 12 items asking the user to rate their satisfaction on a scale of 1 to 5, where 1 = "not satisfied at all" and 5 = "very satisfied". The categories subjects were asked to rate were: Lifting/Lowering (LL), Ramp Ascent (RA), Stair Ascent (SA), Level walking (LW), Ramp Descent (RD), Stair Descent (SD)

    Time frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis), with orthosis reported

  2. Thorax Angle

    This is the global thorax angle (with respect to vertical) during a lifting/lowering cycle. This will be a secondary outcome measure for able-bodied subjects. Extracted at peak trunk lean (bottom of the squat) across 10 post-fatigue cycles. Measured in degrees of decrease in global thorax angle compared with the no-exoskeleton condition.

    Time frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)

  3. Stair Ascent Gait Style

    Step-over-step gait style will be evaluated for the exo condition vs no exo condition for elderly participants.

    Time frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)

07

Results

Posted Nov 18, 2026

Participant flow

First Intervention (without Exo)
Participant flow — First Intervention (without Exo)
MilestoneAble Bodied 1 w/o Device First, Then With DeviceAble Bodied 1 Device First, Then w/o DeviceAble Bodied 2 w/o Device First, Then With DeviceAble Bodied 2 Device First, Then w/o DeviceElderly w/o Device First, Then With DeviceElderly Device First, Then w/o Device
Started446454
Completed446444
Not completed000010
Second Intervention (with Exo)
Participant flow — Second Intervention (with Exo)
MilestoneAble Bodied 1 w/o Device First, Then With DeviceAble Bodied 1 Device First, Then w/o DeviceAble Bodied 2 w/o Device First, Then With DeviceAble Bodied 2 Device First, Then w/o DeviceElderly w/o Device First, Then With DeviceElderly Device First, Then w/o Device
Started446444
Completed446444
Not completed000000

Outcome measures

PrimaryMuscle Effort (% MVC) With and Without Powered Orthosis - Able Bodied 1

For each orthosis module tested, electromyography (EMG) readings will be normalized per-muscle by the peak EMG observed during the no-orthosis condition, and then averaged over the cycle and across repetitions to obtain "normalized exertion" values. Data are presented as Muscle Effort (% Maximum Voluntary Contraction (MVC). Participants completed active movement trials and multi-terrain circuit loops under randomized conditions: 1) Baseline unassisted (No Exoskeleton) and 2) Assisted with active orthosis joint configurations running trajectory-free, task-invariant torque control via energy-shaping algorithms.

Time frame:
1 day
Reported as:
Mean · Muscle Effort (% MVC)
Muscle Effort (% MVC) With and Without Powered Orthosis - Able Bodied 1
Muscle Effort (% MVC)Able Bodied 1: Without OrthosisAble Bodied 1: With Orthosis
BARE - Vastus Medialis (VMO) - Stair Ascent33.887187841224 ± 7.6810749423049—
BARE - Rectus Femoris (RF) - Stair Ascent36.130551156563 ± 11.222455291190—
BARE - Biceps Femoris (BF) - Stair Ascent37.857660844087 ± 11.222472087944—
BARE - Gluteus Maximus (GLUT) - Stair Ascent35.308635582678 ± 11.530122508601—
BARE - Vastus Medialis (VMO) - Stair Descent26.89062659 ± 7.1137223474923—
BARE - Rectus Femoris (RF) - Stair Descent33.32355558 ± 8.6935226502226—
BARE - Biceps Femoris (BF) - Stair Descent18.008695800161 ± 6.3184176183671—
BARE - Gluteus Maximus (GLUT) - Stair Descent15.872367120956 ± 7.6361312369388—
BARE - Vastus Medialis (VMO) - Decline Walking26.01381243 ± 8.7596078012100—
BARE - Rectus Femoris (RF) - Decline Walking31.922145411886 ± 9.6338310891065—
BARE - Biceps Femoris (BF) - Decline Walking18.510995333101 ± 6.9317282676596—
BARE - Gluteus Maximus (GLUT) - Decline Walking15.256456799207 ± 6.1479183262170—
BARE - Vastus Medialis (VMO) - Level Walking8.90473025 ± 3.2483378245204—
BARE - Rectus Femoris (RF) - Level Walking9.8385978644759 ± 4.4030020038817—
BARE - Biceps Femoris (BF) - Level Walking15.369279160997 ± 5.2267456336351—
BARE - Gluteus Maximus (GLUT) - Level Walking14.896358394032 ± 5.9698236919873—
BARE - Vastus Medialis (VMO) - Incline Walking21.386952521881 ± 6.9835455215729—
BARE - Rectus Femoris (RF) - Incline Walking22.441831025994 ± 6.2533226937202—
BARE - Biceps Femoris (BF) - Incline Walking37.358377620674 ± 12.504330863689—
BARE - Gluteus Maximus (GLUT) - Incline Walking33.16334832 ± 9.7834405323076—
BARE - Vastus Medialis (VMO) - Stand Sit Cycle71.159426910594 ± 27.03307555—
BARE - Rectus Femoris (RF) - Stand Sit Cycle77.629740399435 ± 32.400533880317—
BARE - Biceps Femoris (BF) - Stand Sit Cycle52.006694506638 ± 23.590711319504—
BARE - Gluteus Maximus (GLUT) - Stand Sit Cycle47.288882465569 ± 20.425860285071—
HIP BILATERAL - Vastus Medialis (VMO) - Stair Ascent—34.887019724155 ± 8.0329299363843
HIP BILATERAL - Rectus Femoris (RF) - Stair Ascent—34.175183898790 ± 10.558379040315
HIP BILATERAL - Biceps Femoris (BF) - Stair Ascent—39.31261713 ± 9.9135627911961
HIP BILATERAL - Gluteus Maximus (GLUT) - Stair Ascent—36.574630756003 ± 14.089783871097
HIP BILATERAL - Vastus Medialis (VMO) - Stair Descent—28.426617044617 ± 8.4696264634493
HIP BILATERAL - Rectus Femoris (RF) - Stair Descent—30.81723518 ± 10.795365660329
HIP BILATERAL - Biceps Femoris (BF) - Stair Descent—22.133788904854 ± 7.7152852205453
HIP BILATERAL - Gluteus Maximus (GLUT) - Stair Descent—16.361798804663 ± 6.4875895112257
HIP BILATERAL - Vastus Medialis (VMO) - Decline Walking—28.40680906 ± 9.7282329163926
HIP BILATERAL - Rectus Femoris (RF) - Decline Walking—32.004767039758 ± 10.404219512405
HIP BILATERAL - Biceps Femoris (BF) - Decline Walking—19.978603963324 ± 6.0899714941255
HIP BILATERAL - Gluteus Maximus (GLUT) - Decline Walking—14.462444972829 ± 5.5293432658697
HIP BILATERAL - Vastus Medialis (VMO) - Level Walking—11.063512759340 ± 5.0321315380417
HIP BILATERAL - Rectus Femoris (RF) - Level Walking—11.310608181945 ± 6.4665209346354
HIP BILATERAL - Biceps Femoris (BF) - Level Walking—16.792133858157 ± 5.1878589555683
HIP BILATERAL - Gluteus Maximus (GLUT) - Level Walking—15.540084316310 ± 4.8728352674184
HIP BILATERAL - Vastus Medialis (VMO) - Incline Walking—21.308361847529 ± 5.498142528
HIP BILATERAL - Rectus Femoris (RF) - Incline Walking—21.029887205033 ± 8.4578853663992
HIP BILATERAL - Biceps Femoris (BF) - Incline Walking—35.99796281 ± 11.692712930222
HIP BILATERAL - Gluteus Maximus (GLUT) - Incline Walking—33.538144326855 ± 12.131569564049
HIP BILATERAL - Vastus Medialis (VMO) - Stand Sit Cycle—77.35252186 ± 33.155698718153
HIP BILATERAL - Rectus Femoris (RF) - Stand Sit Cycle—78.75466021 ± 36.013813324420
HIP BILATERAL - Biceps Femoris (BF) - Stand Sit Cycle—53.406396350235 ± 22.056968489168
HIP BILATERAL - Gluteus Maximus (GLUT) - Stand Sit Cycle—45.23691184 ± 14.898291554987
HIP UNILATERAL - Vastus Medialis (VMO) - Stair Ascent—30.557272939686 ± 7.168393863
HIP UNILATERAL - Rectus Femoris (RF) - Stair Ascent—31.458243468999 ± 10.264130139094
HIP UNILATERAL - Biceps Femoris (BF) - Stair Ascent—36.314109673195 ± 7.6043325542087
HIP UNILATERAL - Gluteus Maximus (GLUT) - Stair Ascent—32.113290146370 ± 13.129542376906
HIP UNILATERAL - Vastus Medialis (VMO) - Stair Descent—23.309787621443 ± 5.3126186439685
HIP UNILATERAL - Rectus Femoris (RF) - Stair Descent—27.941707852616 ± 7.400397928
HIP UNILATERAL - Biceps Femoris (BF) - Stair Descent—18.731797638273 ± 5.0834466366617
HIP UNILATERAL - Gluteus Maximus (GLUT) - Stair Descent—15.362190727717 ± 8.3879846905768
HIP UNILATERAL - Vastus Medialis (VMO) - Decline Walking—24.919554151740 ± 7.5931918319512
HIP UNILATERAL - Rectus Femoris (RF) - Decline Walking—29.339789545456 ± 8.58673064
HIP UNILATERAL - Biceps Femoris (BF) - Decline Walking—18.033282507387 ± 5.7444802212869
HIP UNILATERAL - Gluteus Maximus (GLUT) - Decline Walking—13.923836823490 ± 6.7165758339868
HIP UNILATERAL - Vastus Medialis (VMO) - Level Walking—9.1280577788174 ± 4.5077511802951
HIP UNILATERAL - Rectus Femoris (RF) - Level Walking—9.9996041578801 ± 5.9642219584815
HIP UNILATERAL - Biceps Femoris (BF) - Level Walking—16.381193569910 ± 4.5633852069054
HIP UNILATERAL - Gluteus Maximus (GLUT) - Level Walking—14.096075840859 ± 6.0809695527673
HIP UNILATERAL - Vastus Medialis (VMO) - Incline Walking—17.916819010500 ± 5.6328724436092
HIP UNILATERAL - Rectus Femoris (RF) - Incline Walking—20.005200939484 ± 7.6253994162103
HIP UNILATERAL - Biceps Femoris (BF) - Incline Walking—29.744091347796 ± 9.1941385127750
HIP UNILATERAL - Gluteus Maximus (GLUT) - Incline Walking—29.675785709713 ± 12.415783262961
HIP UNILATERAL - Vastus Medialis (VMO) - Stand Sit Cycle—63.992088491865 ± 23.739619487200
HIP UNILATERAL - Rectus Femoris (RF) - Stand Sit Cycle—76.171714622490 ± 36.955527336261
HIP UNILATERAL - Biceps Femoris (BF) - Stand Sit Cycle—44.466855746443 ± 15.831705268999
HIP UNILATERAL - Gluteus Maximus (GLUT) - Stand Sit Cycle—41.561584347357 ± 41.561584347357
KNEE BILATERAL - Vastus Medialis (VMO) - Stair Ascent—33.547023647236 ± 15.699306295726
KNEE BILATERAL - Rectus Femoris (RF) - Stair Ascent—37.631989795988 ± 15.018897719695
KNEE BILATERAL - Biceps Femoris (BF) - Stair Ascent—45.105442873007 ± 14.181012143412
KNEE BILATERAL - Gluteus Maximus (GLUT) - Stair Ascent—56.93970866 ± 16.089185358511
KNEE BILATERAL - Vastus Medialis (VMO) - Stair Descent—28.734279007380 ± 12.803180669976
KNEE BILATERAL - Rectus Femoris (RF) - Stair Descent—37.256820163673 ± 15.647647925985
KNEE BILATERAL - Biceps Femoris (BF) - Stair Descent—26.090669575164 ± 7.8275101191662
KNEE BILATERAL - Gluteus Maximus (GLUT) - Stair Descent—26.060951621644 ± 14.542103085287
KNEE BILATERAL - Vastus Medialis (VMO) - Decline Walking—25.929086313111 ± 12.070117938470
KNEE BILATERAL - Rectus Femoris (RF) - Decline Walking—31.962328475160 ± 11.271358486429
KNEE BILATERAL - Biceps Femoris (BF) - Decline Walking—20.022683393847 ± 6.8826399251759
KNEE BILATERAL - Gluteus Maximus (GLUT) - Decline Walking—19.555111691492 ± 8.5773032128057
KNEE BILATERAL - Vastus Medialis (VMO) - Level Walking—14.558686062768 ± 4.3141426848920
KNEE BILATERAL - Rectus Femoris (RF) - Level Walking—14.177587403852 ± 7.6700608091222
KNEE BILATERAL - Biceps Femoris (BF) - Level Walking—18.788292114371 ± 9.1275626246146
KNEE BILATERAL - Gluteus Maximus (GLUT) - Level Walking—21.431169000247 ± 8.5209599057584
KNEE BILATERAL - Vastus Medialis (VMO) - Incline Walking—20.216411619688 ± 10.936416746878
KNEE BILATERAL - Rectus Femoris (RF) - Incline Walking—21.977697136970 ± 10.331109022759
KNEE BILATERAL - Biceps Femoris (BF) - Incline Walking—39.277194237640 ± 18.472651029130
KNEE BILATERAL - Gluteus Maximus (GLUT) - Incline Walking—45.622775924455 ± 14.543403783129
KNEE BILATERAL - Vastus Medialis (VMO) - Stand Sit Cycle—59.34141979 ± 42.900567533085
KNEE BILATERAL - Rectus Femoris (RF) - Stand Sit Cycle—61.597386942684 ± 46.65885237
KNEE BILATERAL - Biceps Femoris (BF) - Stand Sit Cycle—49.648592568233 ± 25.531725102560
KNEE BILATERAL - Gluteus Maximus (GLUT) - Stand Sit Cycle—46.969562202638 ± 22.790823800647
KNEE UNILATERAL - Vastus Medialis (VMO) - Stair Ascent—27.511615425730 ± 11.968935486044
KNEE UNILATERAL - Rectus Femoris (RF) - Stair Ascent—29.796357536863 ± 9.3224063189778
KNEE UNILATERAL - Biceps Femoris (BF) - Stair Ascent—37.327276657096 ± 10.471705525761
KNEE UNILATERAL - Gluteus Maximus (GLUT) - Stair Ascent—38.457339295197 ± 14.305192866717
KNEE UNILATERAL - Vastus Medialis (VMO) - Stair Descent—22.583211397798 ± 8.2649467504421
KNEE UNILATERAL - Rectus Femoris (RF) - Stair Descent—26.723273051711 ± 6.9100402095087
KNEE UNILATERAL - Biceps Femoris (BF) - Stair Descent—17.830434769382 ± 6.5263764018533
KNEE UNILATERAL - Gluteus Maximus (GLUT) - Stair Descent—18.394505135561 ± 8.5775126690267
KNEE UNILATERAL - Vastus Medialis (VMO) - Decline Walking—22.168556450131 ± 10.30921476
KNEE UNILATERAL - Rectus Femoris (RF) - Decline Walking—26.658100157732 ± 7.4886630168186
KNEE UNILATERAL - Biceps Femoris (BF) - Decline Walking—17.403907608170 ± 6.6949523140704
KNEE UNILATERAL - Gluteus Maximus (GLUT) - Decline Walking—16.685700226561 ± 6.488186651
KNEE UNILATERAL - Vastus Medialis (VMO) - Level Walking—10.980611289672 ± 4.2962490697954
KNEE UNILATERAL - Rectus Femoris (RF) - Level Walking—10.971384069935 ± 4.5761785130242
KNEE UNILATERAL - Biceps Femoris (BF) - Level Walking—13.52207812 ± 4.262612408
KNEE UNILATERAL - Gluteus Maximus (GLUT) - Level Walking—19.682798857130 ± 7.7534082351244
KNEE UNILATERAL - Vastus Medialis (VMO) - Incline Walking—16.815658523150 ± 5.5663406440699
KNEE UNILATERAL - Rectus Femoris (RF) - Incline Walking—17.462644623327 ± 5.4672997047989
KNEE UNILATERAL - Biceps Femoris (BF) - Incline Walking—31.382472868084 ± 11.726410757309
KNEE UNILATERAL - Gluteus Maximus (GLUT) - Incline Walking—36.252775416641 ± 9.2533322102647
KNEE UNILATERAL - Vastus Medialis (VMO) - Stand Sit Cycle—50.494278375684 ± 28.724065499894
KNEE UNILATERAL - Rectus Femoris (RF) - Stand Sit Cycle—58.769489599426 ± 29.519784441933
KNEE UNILATERAL - Biceps Femoris (BF) - Stand Sit Cycle—41.356263036694 ± 20.139622801561
KNEE UNILATERAL - Gluteus Maximus (GLUT) - Stand Sit Cycle—46.90339263 ± 20.481864636128
PrimaryQuadriceps Muscle Effort (% MVC) With and Without Powered Orthosis - Able Bodied 2

We estimated quadriceps effort during six different lifting, lowering, and carrying (LLC) tasks (lifting-lowering (LL), level walking (LW), ramp ascent (RA), ramp descent (RD), stair ascent (SA), and stair descent (SD)) for the no-exo and exo conditions in a nonfatigued state. Muscle effort was calculated as the mean root mean square EMG, normalized to % maximum voluntary contraction (%MVC), over the gait/task cycle. Quadriceps effort was estimated by taking the weighted mean of the efforts of the vastus medialis oblique (VMO), vastus lateralis (VL), and rectus femoris (RF) based on their respective physiological cross-sectional areas.

Time frame:
1 day
Reported as:
Mean · % MVC
Quadriceps Muscle Effort (% MVC) With and Without Powered Orthosis - Able Bodied 2
% MVCAble Bodied 2: Without OrthosisAble Bodied 2: With Orthosis
Lifting-lowering (LL)25.39392547 ± 7.048688119.74086721 ± 5.281409738
Ramp Ascent (RA)13.36036878 ± 6.51643221311.09373192 ± 5.456759946
Stair Ascent (SA)18.18997983 ± 9.16695786213.62986533 ± 5.790605194
Ramp Descent (RD)15.9386677 ± 6.73385098514.60594334 ± 6.884032713
Stair Descent (SD)16.47382229 ± 8.21855327614.56048643 ± 6.438120934
Level Walking (LW)7.836225154 ± 3.5968479757.56271423 ± 3.56607281
PrimaryTime to Complete 10 Reps of Lifting/Lowering

Time to complete 10 reps of L\&L will be measured post-fatigue in healthy subjects. The reported outcome is measured in seconds to completion.

Time frame:
1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
Reported as:
Mean · time in seconds
Time to Complete 10 Reps of Lifting/Lowering
time in secondsAble Bodied 2: Without OrthosisAble Bodied 2: With Orthosis
Time to Complete 10 Reps of Lifting/Lowering52.11 ± 15.7922394636.15666667 ± 4.986625322
PrimaryGait Speed

Gait speed will be determined by the time to complete a 10-meter walk test. This will be the primary outcome measure for elderly subjects.

Time frame:
1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)

No measurements were reported for this outcome.

PrimaryPowered Orthosis Effect (Biological Torque)

For each orthosis module tested, peak biological torque (estimated by inverse dynamics) will be averaged across repetitions. Performance will be assessed by the difference between the orthosis condition and no-orthosis condition, averaging across tasks. Participants walked on a Bertec instrumented treadmill with a level slope at 1.0 and 1.2 m/s, a 5◦-inclined and 5◦-declined slope at 1.0 m/s, and a 10◦-inclined and 10◦-declined slope at 0.8 m/s. Participants also performed stair ascent and descent on a 5-step staircase with 7 in (178 mm) step height, and STS transitions from a knee-height chair. All activities were performed both with the powered exoskeleton and without. Results are presented as mean torque (Newton-meters per kilogram (Nm/kg).

Time frame:
1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
Reported as:
Mean · Torque (Nm/kg)
Powered Orthosis Effect (Biological Torque)
Torque (Nm/kg)Exoskeleton - Elderly: Without OrthosisExoskeleton - Elderly: With Orthosis
Level Ground 1.0 m/s0.4754 ± 0.11260.4041 ± 0.1035
Level Ground 1.2 m/s0.5796 ± 0.14730.5042 ± 0.0895
Ramp Ascent 5 degrees0.5373 ± 0.10830.4777 ± 0.1286
Ramp Ascent 10 degrees0.5896 ± 0.08980.4585 ± 0.1344
Stair Ascent1.2046 ± 0.28660.9801 ± 0.399
Sit-to-Stand0.78 ± 0.21060.6341 ± 0.1779
PrimaryMinimum Chair Height for Successful Sit-to-stand

We will evaluate the minimum chair height from which elderly participants can successfully rise with and without the knee exoskeleton.

Time frame:
1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
Reported as:
Mean · inches
Minimum Chair Height for Successful Sit-to-stand
inchesExoskeleton - Elderly: Without OrthosisExoskeleton - Elderly: With Orthosis
Minimum Chair Height for Successful Sit-to-stand16.00 ± 2.3114.25 ± 2.63
PrimaryJoint Power

For elderly participants, we will evaluate the peak values of biological and total (exo+biological) joint power at the hip with and without the exoskeleton. Results presented as mean power in watts per kilogram (W/kg).

Time frame:
1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
Reported as:
Mean · Power (W/kg)
Joint Power
Power (W/kg)Exoskeleton - Elderly: Without OrthosisExoskeleton - Elderly: With Orthosis
Level Ground1.0 m/s (biological)0.7356 ± 0.17830.706 ± 0.2983
Level Ground 1.0 m/s (exo + bio)0.7356 ± 0.17830.9855 ± 0.3533
Level Ground 1.2 m/s (biological)0.9335 ± 0.2350.9788 ± 0.3406
Level Ground 1.2 m/s (exo + bio)0.9335 ± 0.2351.2676 ± 0.3815
Ramp Ascent 5 (degrees) (biological)0.9682 ± 0.1980.8093 ± 0.2753
Ramp Ascent 5 (degrees) (exo + bio))0.9682 ± 0.1981.1145 ± 0.3172
Ramp Ascent 10 (degrees) (biological)0.9798 ± 0.20950.7932 ± 0.2557
Ramp Ascent 10 (degrees) (exo + bio)0.9798 ± 0.20951.1249 ± 0.2779
Stair Ascent (biological)2.3544 ± 0.72761.9235 ± 0.7198
Stair Ascent (exo + bio)2.3544 ± 0.72762.4858 ± 0.7458
Sit-to-Stand (biological)1.478 ± 1.02991.1623 ± 0.9483
Sit-to-Stand (exo + bio)1.478 ± 1.02991.6599 ± 1.3195
SecondaryUser Satisfaction

User satisfaction / perception of device effectiveness over an ambulation circuit (sit-to-stand, walk up and down a ramp, walk up and down a staircase) will be measured post-fatigue in healthy subjects using a modified Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) survey. The purpose of the scale is to evaluate user device satisfaction and consists of 12 items asking the user to rate their satisfaction on a scale of 1 to 5, where 1 = "not satisfied at all" and 5 = "very satisfied". The categories subjects were asked to rate were: Lifting/Lowering (LL), Ramp Ascent (RA), Stair Ascent (SA), Level walking (LW), Ramp Descent (RD), Stair Descent (SD)

Time frame:
1 day, assessed per experimental condition (i.e. with orthosis and without orthosis), with orthosis reported
Reported as:
Mean · score on a scale
User Satisfaction
score on a scaleExoskeleton - Able Bodied 2: Without OrthosisExoskeleton - Able Bodied 2: With Orthosis
Lifting/Lowering (LL)—4.8 ± 0.421637021
Ramp Ascent (RA)—4.2 ± 0.421637021
Stair Ascent (SA)—4.8 ± 0.421637021
Level walking (LW)—3.6 ± 0.699205899
Ramp Descent (RD)—4.2 ± 0.788810638
Stair Descent (SD)—4.3 ± 1.059349905
SecondaryThorax Angle

This is the global thorax angle (with respect to vertical) during a lifting/lowering cycle. This will be a secondary outcome measure for able-bodied subjects. Extracted at peak trunk lean (bottom of the squat) across 10 post-fatigue cycles. Measured in degrees of decrease in global thorax angle compared with the no-exoskeleton condition.

Time frame:
1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
Reported as:
Mean · Degrees
Thorax Angle
DegreesExoskeleton - Able Bodied 2: Without OrthosisExoskeleton - Able Bodied 2: With Orthosis
Thorax Angle53.271 ± 9.07248.918 ± 9.448
SecondaryStair Ascent Gait Style

Step-over-step gait style will be evaluated for the exo condition vs no exo condition for elderly participants.

Time frame:
1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
Reported as:
Count of participants · Participants
Stair Ascent Gait Style
ParticipantsExoskeleton - Elderly: Without OrthosisExoskeleton - Elderly: With Orthosis
Stair Ascent Gait Style78

Adverse events

Collected over 2 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Able Bodied 1 Without Device0/4 (0%)0/4 (0%)0/4 (0%)
Able Bodied 1 With Device0/4 (0%)0/4 (0%)0/4 (0%)
Able Bodied 2 Without Device0/6 (0%)0/6 (0%)0/6 (0%)
Able Bodied 2 With Device0/4 (0%)0/4 (0%)0/4 (0%)
Elderly Without Device0/4 (0%)0/4 (0%)1/4 (25%)
Elderly With Device0/4 (0%)0/4 (0%)0/4 (0%)
Most frequent other events
Most frequent other events
EventAble Bodied 1 Without DeviceAble Bodied 1 With DeviceAble Bodied 2 Without DeviceAble Bodied 2 With DeviceElderly Without DeviceElderly With Device
Non-Serious Adverse EventInjury, poisoning and procedural complications0/40/40/60/41/40/4

Baseline characteristics

Age, sex, race/ethnicity, and weight were collected for all baseline participants. Height was not collected or reported for group 1. For group 3 (Exoskeleton - elderly), 9 participants were consented and enrolled but only 8 had baseline characteristics collected and finished the study.

Age, Categorical
Age, Categorical(Participants)Exoskeleton - Able Bodied 1Exoskeleton - Able Bodied 2Exoskeleton - ElderlyTotal
<=18 years0000
Between 18 and 65 years810018
>=65 years0099
Sex: Female, Male
Sex: Female, Male(Participants)Exoskeleton - Able Bodied 1Exoskeleton - Able Bodied 2Exoskeleton - ElderlyTotal
Female45413
Male45514
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Exoskeleton - Able Bodied 1Exoskeleton - Able Bodied 2Exoskeleton - ElderlyTotal
Race/Ethnicity — White Non-Hispanic46919
Race/Ethnicity — Black or African American0000
Race/Ethnicity — Asian3306
Race/Ethnicity — Hispanic or Latino1102
Weight
Weight(Mass (kg))Exoskeleton - Able Bodied 1Exoskeleton - Able Bodied 2Exoskeleton - ElderlyTotal
Mean69.25 ± 12.1769.9 ± 13.2469.11 ± 7.0369.46 ± 10.89
Height
Height(Height (meters))Exoskeleton - Able Bodied 1Exoskeleton - Able Bodied 2Exoskeleton - ElderlyTotal
Mean—1.70 ± 0.071.72 ± 0.041.71 ± 0.06
08

Study locations

1 site
09

References and documents

Publications

  • Zhang J, Divekar NV, Krishnan C, Gregg RD. Versatile Exoskeleton Control Supports Elderly Joint Energetics During Hip-Intensive Tasks. IEEE Trans Neural Syst Rehabil Eng. 2026;34:3993-4004. doi: 10.1109/TNSRE.2026.3732581. PubMed 42721171 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2022 to primary completion in Aug 2025, 36 months.

Results were first posted in Nov 2026, 1 year 3 months after primary completion.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's 36 months is above that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Sep 2026 → Aug 2025 and completion Sep 2026 → Aug 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2022
First posted
Feb 15, 2022
StartActual
Jul 29, 2022
Primary completionActual
Aug 6, 2025was Sep 2026
CompletionActual
Aug 6, 2025was Sep 2026
Results first posted
Nov 18, 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 18, 2026
Results
Results posted
posted Nov 18, 2026
Primary completion
Sep 20, 2026→Aug 6, 2025 (actual)
Nov 18, 2026
Study completion
Sep 21, 2026→Aug 6, 2025 (actual)
Nov 18, 2026
Enrollment
33 (estimated)→27 (actual)
Nov 18, 2026
Primary outcomes
5 edited, 2 added, 1 removed
What changed in the outcomes
  • EditedPowered orthosis effectOrthosis Effect (muscle effortBiological Torque)Time frame: 1 day → 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
  • EditedTime to completeComplete 10 repsReps of liftingLifting/loweringLoweringTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
  • EditedGait speedSpeedTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
  • EditedMinimum chair heightChair Height for successful sitSuccessful Sit-to-standTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
  • EditedJoint powerPowerTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
  • AddedMuscle Effort (% MVC) With and Without Powered Orthosis - Able Bodied 1Time frame: 1 day
  • AddedQuadriceps Muscle Effort (% MVC) With and Without Powered Orthosis - Able Bodied 2Time frame: 1 day
  • RemovedPowered orthosis effect (biological torque)Time frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
Nov 18, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 42721171 ↗
Nov 18, 2026
Secondary outcomes
3 edited
What changed in the outcomes
  • EditedUser satisfactionSatisfactionTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis) → 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis), with orthosis reported
  • EditedThorax angleAngleTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
  • EditedStair ascent gait styleAscent Gait StyleTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Recruiting→Completed
    Results posted
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 42721171 ↗
    Primary completion Sep 20, 2026→Aug 6, 2025 (now actual)
    Study completion Sep 21, 2026→Aug 6, 2025 (now actual)
    Enrollment 33 (estimated)→27 (actual)
    Primary outcomes 5 edited, 2 added, 1 removed
    What changed in the outcomes
    • EditedPowered orthosis effectOrthosis Effect (muscle effortBiological Torque)Time frame: 1 day → 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
    • EditedTime to completeComplete 10 repsReps of liftingLifting/loweringLoweringTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
    • EditedGait speedSpeedTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
    • EditedMinimum chair heightChair Height for successful sitSuccessful Sit-to-standTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
    • EditedJoint powerPowerTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
    • AddedMuscle Effort (% MVC) With and Without Powered Orthosis - Able Bodied 1Time frame: 1 day
    • AddedQuadriceps Muscle Effort (% MVC) With and Without Powered Orthosis - Able Bodied 2Time frame: 1 day
    • RemovedPowered orthosis effect (biological torque)Time frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
    Secondary outcomes 3 edited
    What changed in the outcomes
    • EditedUser satisfactionSatisfactionTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis) → 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis), with orthosis reported
    • EditedThorax angleAngleTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
    • EditedStair ascent gait styleAscent Gait StyleTime frame: 1 day, assessed per experimental condition (i.e. with orthosis and without orthosis)
    + 4 other changes: verification date, contact details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05240014
Responsible party
Robert D Gregg (Associate Professor, University of Michigan) — Principal investigator
First posted
Feb 15, 2022
Start date
Jul 29, 2022
Primary completion
Aug 6, 2025
Completion
Aug 6, 2025
Results posted
Nov 18, 2026
Last update
Nov 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion